Filters

Term Search
You can select from the dropdown list OR enter your own terms to refine the search.

Last Updated: 10/31/2025

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 5807 publications

Efficiency of mild ovarian stimulation with letrozole co-treatment in expected low ovarian responders.

Efficiency of mild ovarian stimulation with letrozole co-treatment in expected low ovarian responders.

Journal: JBRA assisted reproduction
Published: October 08, 2025

Sequential therapy for infertility in women with polycystic ovary syndrome and luteal phase defects by Yangxin Dianji decoction and Nuangong Tiaojing decoction: a real-world study.

Sequential therapy for infertility in women with polycystic ovary syndrome and luteal phase defects by Yangxin Dianji decoction and Nuangong Tiaojing decoction: a real-world study.

Journal: Journal of traditional Chinese medicine = Chung i tsa chih ying wen pan
Published: September 28, 2025

Ribociclib Plus Endocrine Therapy in Hormone Receptor-Positive/ERBB2-Negative Early Breast Cancer: 4-Year Outcomes From the NATALEE Randomized Clinical Trial.

Ribociclib Plus Endocrine Therapy in Hormone Receptor-Positive/ERBB2-Negative Early Breast Cancer: 4-Year Outcomes From the NATALEE Randomized Clinical Trial.

Journal: JAMA oncology
Published: September 25, 2025

Rethinking Ribociclib Dosage and Use in the Era of Patient-Centered Oncology-When Less Is More.

Rethinking Ribociclib Dosage and Use in the Era of Patient-Centered Oncology-When Less Is More.

Journal: JAMA oncology
Published: September 25, 2025

600- vs 400-mg First-Line Ribociclib in Hormone Receptor-Positive/ERBB2-Negative Advanced Breast Cancer: The AMALEE Randomized Clinical Trial.

600- vs 400-mg First-Line Ribociclib in Hormone Receptor-Positive/ERBB2-Negative Advanced Breast Cancer: The AMALEE Randomized Clinical Trial.

Journal: JAMA oncology
Published: September 25, 2025

The stereological investigation of conditioned medium originated from human adipose tissue-derived mesenchymal stem cells and platelet-rich plasma effects on polycystic ovary syndrome in a rat model.

The stereological investigation of conditioned medium originated from human adipose tissue-derived mesenchymal stem cells and platelet-rich plasma effects on polycystic ovary syndrome in a rat model.

Journal: Zygote (Cambridge, England)
Published: September 24, 2025

Comparative effects of growth hormone, testosterone, and aromatase inhibitors on height gain in children and adolescents with idiopathic short statures: a network meta-analysis.

Comparative effects of growth hormone, testosterone, and aromatase inhibitors on height gain in children and adolescents with idiopathic short statures: a network meta-analysis.

Journal: Annals of human biology
Published: September 17, 2025

Genetic variations in CYP2A6 predict efficacy of neoadjuvant letrozole concurrent with chemotherapy in locally advanced hormone receptor-positive breast cancer.

Genetic variations in CYP2A6 predict efficacy of neoadjuvant letrozole concurrent with chemotherapy in locally advanced hormone receptor-positive breast cancer.

Journal: Annals of medicine
Published: September 17, 2025

Peripheral Precocious Puberty Due to Autonomous Gonadal Activation: A Multicenter Experience.

Peripheral Precocious Puberty Due to Autonomous Gonadal Activation: A Multicenter Experience.

Journal: Cureus
Published: September 13, 2025

Treatment consequence and adverse events of cyclin-dependent kinase 4/6 inhibitors on patients with hormone receptor-positive, HER2-negative metastatic breast cancer: a systematic review and meta-analysis.

Treatment consequence and adverse events of cyclin-dependent kinase 4/6 inhibitors on patients with hormone receptor-positive, HER2-negative metastatic breast cancer: a systematic review and meta-analysis.

Journal: Annals of medicine
Published: September 09, 2025

From Haemorrhagic Shock to Years of Survival: A Case Report of PIK3CA-Mutated Estrogen Receptor-Positive and Human Epidermal Growth Factor Receptor 2-Negative (ER+/HER2-) Metastatic Breast Cancer With Satellite Lesions.

From Haemorrhagic Shock to Years of Survival: A Case Report of PIK3CA-Mutated Estrogen Receptor-Positive and Human Epidermal Growth Factor Receptor 2-Negative (ER+/HER2-) Metastatic Breast Cancer With Satellite Lesions.

Journal: Cureus
Published: September 08, 2025

Matching-adjusted indirect comparison of ribociclib + nonsteroidal aromatase inhibitor versus abemaciclib + endocrine therapy in hormone receptor-positive/HER2-negative early breast cancer.

Matching-adjusted indirect comparison of ribociclib + nonsteroidal aromatase inhibitor versus abemaciclib + endocrine therapy in hormone receptor-positive/HER2-negative early breast cancer.

Journal: Journal of comparative effectiveness research
Published: August 29, 2025
Showing 1-12 of 5,807

Last Updated: 10/31/2025